Supplementary Table 1: List of FDA Approved SMIs as of April 1st, 2025

Published: 17 December 2025| Version 1 | DOI: 10.17632/hbdrm9s6yz.1
Contributor:
Ian Nykaza

Description

List of FDA Approved SMIs as of April 1st, 2025 with their FDA-approved indications and targeted pathways.

Files

Institutions

  • Memorial Sloan Kettering Cancer Center
  • Stanford University
  • Cornell University Joan and Sanford I Weill Medical College

Categories

Dermatology, Oncology, Toxicity

Licence